Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).

Halfon P, Pérusat S, Bourlière M, Bronowicki JP, Trimoulet P, Benhamou Y, Leroy V, Marcellin P, Foucher J, Penaranda G, Chêne G, Couzigou P, ANRS HC16 GAMMATRI Study Group

Open source

DOI: 10.1002/jmv.21909
Published: 2010 Dec
Container: Journal of medical virology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jmv.21909,
  title = {Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).},
  author = {Halfon P and Pérusat S and Bourlière M and Bronowicki JP and Trimoulet P and Benhamou Y and Leroy V and Marcellin P and Foucher J and Penaranda G and Chêne G and Couzigou P and ANRS HC16 GAMMATRI Study Group},
  year = {2010},
  journal = {Journal of medical virology},
  doi = {10.1002/jmv.21909},
  url = {https://doi.org/10.1002/jmv.21909}
}

RIS

TY  - JOUR
TI  - Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
AU  - Halfon P
AU  - Pérusat S
AU  - Bourlière M
AU  - Bronowicki JP
AU  - Trimoulet P
AU  - Benhamou Y
AU  - Leroy V
AU  - Marcellin P
AU  - Foucher J
AU  - Penaranda G
AU  - Chêne G
AU  - Couzigou P
AU  - ANRS HC16 GAMMATRI Study Group
PY  - 2010
JO  - Journal of medical virology
DO  - 10.1002/jmv.21909
UR  - https://doi.org/10.1002/jmv.21909
ER  -

APA

P, H., S, P., M, B., JP, B., P, T., Y, B., V, L., P, M., J, F., G, P., G, C., P, C., & Group, A. H. G. S. (2010). Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).. Journal of medical virology. https://doi.org/10.1002/jmv.21909

Source records

pubmed · retrieved 2026-09-25T04:48:57.643Z
europe-pmc · retrieved 2026-09-25T04:48:57.675Z
hal · retrieved 2026-09-25T04:48:57.701Z